Aqylon Nexus to seek board approval for 51% stake acquisition in E Trav Tech

What Aqylon Nexus announced

Aqylon Nexus Ltd (formerly Sri Adhikari Brothers Television Network Ltd) informed the Bombay Stock Exchange that its Board of Directors will convene on Thursday, 9 July 2026. The agenda includes:

1. Approval of a proposed acquisition of a 51% equity stake in M/s E Trav Tech Limited (the “Target Company”) through a share‑swap arrangement involving a preferential issue of Aqylon Nexus equity shares.
2. Consideration of a fund‑raising plan that may involve issuance of equity shares, convertible bonds, debentures, convertible warrants, preference shares or other equity‑linked securities via private placement, preferential issue or qualified institutional placement.
3. Alteration of the main object clause of the company’s memorandum of association.
4. Any other business with the Chairperson’s permission.

The notice complies with the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and was filed on 6 July 2026.

Acquisition details

The core transaction is the purchase of a 51% equity stake in E Trav Tech Limited. The acquisition will be executed by way of a share‑swap, meaning Aqylon Nexus will issue its own equity shares to the shareholders of E Trav Tech in exchange for the target’s shares. The share‑swap will be carried out through a preferential issue, which requires the approval of existing shareholders and compliance with the Companies Act, 2013 and SEBI’s Capital and Disclosure Requirements Regulations, 2018.

Key points from the filing:

• The transaction is subject to all requisite statutory, regulatory, contractual, and other approvals, consents, permissions, and compliances.
• No monetary valuation of the target or the number of shares to be issued has been disclosed in the notice.
• The acquisition aims to give Aqylon Nexus a controlling interest in the target, potentially expanding its footprint in the travel‑technology sector.

Funding and other board items

Alongside the acquisition, the Board will consider a flexible fund‑raising programme. The company may raise capital through any of the following instruments:

• Equity shares (including preferential issues);
• Convertible bonds;
• Debentures;
• Convertible warrants;
• Preference shares;
• Other equity‑linked securities.

All issuances would be undertaken through permissible modes such as private placement, qualified institutional placement, or any other method allowed under the Companies Act, 2013 and SEBI regulations. The filing does not specify the target amount, pricing, or timeline for the fund‑raising.

The Board will also propose an alteration, addition, replacement, or deletion of the main object clause of Aqylon Nexus. The specific changes to the object clause are not detailed in the notice.

Key facts at a glance

Why this matters for investors

The proposed acquisition, if approved, would give Aqylon Nexus a controlling interest in E Trav Tech, potentially diversifying its business beyond its traditional media operations. The share‑swap mechanism means that existing shareholders of the target will become shareholders of Aqylon Nexus, diluting the current share base of Aqylon Nexus unless offset by the value created from the acquisition.

The fund‑raising plan signals that the company may need additional capital to finance the transaction or to support broader strategic initiatives. Depending on the instrument chosen, investors could face dilution (equity issuance) or potential debt‑like obligations (convertible bonds, debentures).

Amending the main object clause could broaden the company’s permissible business activities, which may affect future strategic direction and risk profile. All actions are contingent on regulatory and shareholder approvals, and the filing does not guarantee that any of the proposals will be implemented.

Conclusion

Aqylon Nexus has formally notified the market of a board meeting on 9 July 2026 to consider a 51% share‑swap acquisition of E Trav Tech, a flexible fund‑raising programme, and an amendment to its main object clause. The proposals are subject to multiple approvals and the exact terms—including valuation, amount of capital to be raised, and the nature of the object‑clause change—remain undisclosed. Investors should monitor subsequent disclosures for detailed terms and regulatory clearances.